This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24/7 Access
Digital & In-Person
JOIN NOW
Menu
JOIN
Peptide Discoverykeyboard_arrow_right

Peptide Discovery

keyboard_arrow_leftSearch & Filter
search

Peptide Discovery

search
PEPTIDE DISCOVERY: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures
On Demand - For MembersFree
On-Demand Presentations
Discovery and Development of Semaglutide – The First Orally Available GLP-1 Peptide for Treatment of Type 2 Diabetes
  • Jesper Lau, PhD - Vice President, Protein and Peptide Chemistry, Novo Nordisk A/S
On Demand Free
Webinars
Chromatographic Peptide Purification for Progressing Early Drug Discovery Projects
    On Demand - Premium Only
    On-Demand Presentations
    Discovery and Development of Zilucoplan, A Macrocyclic Peptide Inhibitor of Complement C5
    • Camil Sayegh, PhD - Head of Complement Biology and Macrocycle Peptide Platform, UCB Ra Pharma
    On Demand - Premium Only
    Webinars
    A Strategic Vision for Therapeutic Development: The PeptiDream Story
    • Patrick Reid, PhD - CEO, PeptiDream, Inc.
    On Demand - Premium Only
    On-Demand Presentations
    Peptides Past, Present and Future:A Peptide Drug Hunter Odyssey
    • Tomi Sawyer, Ph.D. - Chief Drug Hunter & President, Maestro Therapeutics
    On Demand - Premium Only
    On-Demand Presentations
    mRNA-Display Selected Cyclic Peptide Affinity Probes for Enzyme-substrate Complex Capture
    • Tom McAllister, PhD - Senior Research Associate, Newcastle University
    On Demand - Premium Only
    On-Demand Presentations
    Application of Diselenide-selenoester Ligation towards the Synthesis of Phosphorylated IGFBP-2
    • Bhavesh Premdjee, Ph.D. - Senior Scientist, Research Chemistry, Novo Nordisk A/S
    On Demand - Premium Only
    On-Demand Presentations
    Phage Display Selection of Peptides that Resist Proteases in the Gastrointestinal Tract
    • Vanessa Carle - Postdoctoral Researcher, EPFL (École polytechnique fédérale de La
    On Demand - Premium Only
    On-Demand Presentations
    Platforms for the Generation and High-throughput Screening of Microcycle Libraries for Inhibitors Protein-protein and Protein-DNA Interactions
    • Ali Tavassoli, Ph.D. - CSO, Curve Therapeutics, University of Southampton
    On Demand - Premium Only
    On-Demand Presentations
    Endosomal Escape Vehicles and Their Mechanism of Action
    • Dehua Pei, PhD - Professor, Department of Chemistry and Biochemistry, Ohio State University
    On Demand - Premium Only
    On-Demand Presentations
    Design of Long-acting Y2 Receptor Selective PYY3-36 Analogues
    • Soren Ostergaard, Ph.D. - Principal Scientist, Novo Nordisk A/S
    On Demand - Premium Only
    On-Demand Presentations
    PL8177 OCD - Alignment of Receptor, Oral Formulation and Peptide for Maximal Therapeutic Ratio in IBD
    • John Dodd, Ph.D. - Vice President, Preclinical Development, Palatin Technologies, Inc.
    On Demand - Premium Only
    On-Demand Presentations
    Ciraparantag: A Novel Anticoagulant Reversal Agent
    • Helene Shea - CMC Senior Director, AMAG Pharmaceuticals
    On Demand - Premium Only
    On-Demand Presentations
    Five Pre-clinical PoC studies and the Clinical Phase I Study of the Orally Available All-D-enantiomeric Peptide PRI-002 for the Treatment of Alzheimer’s Disease
    • Dieter Willbold, Ph.D. - Director, ICS-6 Structural Biochemistry, Forschungszentrum Jülich, Germany
    On Demand - Premium Only
    On-Demand Presentations
    Peptides in Food Science – Promoting Health and Assuring Safety
    • Michelle Colgrave - Professor of Food and Agricultural Proteomics, CSIRO
    On Demand - Premium Only
    On-Demand Presentations
    Overview of CIPPS and Peptide Science in Australia
    • Annie Kan - Senior Research Administration Officer, University of Queensland
    On Demand - Premium Only
    On-Demand Presentations
    The Commercial Development of a Peptide for Human Fungal Toenail Infections (Onychomycosis)
    • Nicole Van Der Weerden - Chief Executive Officer, Hexima Ltd
    On Demand - Premium Only
    On-Demand Presentations
    Toward Peptide-based Approaches for Safeguarding the Great Barrier Reef
    • Conan Wang - Senior Research Officer, Institute for Molecular Bioscience, University of Queensland
    On Demand - Premium Only
    On-Demand Presentations
    Bringing Peptides to Market: Regula(tory) Rom-com or Horror Movie?
    • Nick Watts - Research Director, Innovate Ag
    On Demand - Premium Only
    On-Demand Presentations
    Drug Discovery to Late Stage Development of Peptides: Challenges and Learnings in Optimizing Pipeline Progression and Establishing a Sustainable Corporate Strategy
    • Gökhan Batur - CEO, Polyphor Ltd
    On Demand - Premium Only
    On-Demand Presentations
    Circular Economy and Green Solid-Phase Peptide Synthesis
    • Fernando Albericio - Professor, Organic Chemistry, University of Barcelona
    On Demand - Premium Only
    On-Demand Presentations
    Constrained Natural Peptides from Venoms
    • Michel De Waard, PhD - Scientific Consultant, Smartox Biotechnology
    On Demand - Premium Only
    On-Demand Presentations
    Nature-Derived Peptides as Novel Tools to Study GPCR Signaling
    • Christian Gruber, PhD - Research Group Leader and Associate Professor, Medical University of Vienna
    On Demand - Premium Only
    On-Demand Presentations
    Target Fishing with Peptide Natural Products by Chemogenomics
    • Dominic Hoepfner, Ph.D. - Scientist, Novartis Institutes for BioMedical Research
    On Demand - Premium Only
    On-Demand Presentations
    A Nonclinical Case Study for the Pharmacokinetic Evaluation of a Peptide Therapeutic
    • Bruce Morimoto, PhD - Vice President, Cerecin
    On Demand - Premium Only
    On-Demand Presentations
    Improved Recovery, Reproducibility, and Spectral Quality of Peptides Using a Specialized LC Surface
    • Jennifer Nguyen - PhD Student, University of Copenhagen
    On Demand - Premium Only
    On-Demand Presentations
    Five Pre-clinical PoC studies and the Clinical Phase I Study of the Orally Available All-D-enantiomeric Peptide PRI-002 for the Treatment of Alzheimer’s Disease
    • Dieter Willbold, Ph.D. - Director, ICS-6 Structural Biochemistry, Forschungszentrum Jülich, Germany
    On Demand - Premium Only
    On-Demand Presentations
    Introduction to General Side Reactions in Peptide Synthesis and Prediction of Peptide Drug Chemical Stability
    • Yi Yang, Ph.D. - Senior Research Scientist, Chemical Development &, Ferring Pharmaceuticals A/S
    Peptide CMC
    NextmRNA Therapeutics & Genome Editing
    Filter
    Free / Premium
    Topics
    Choose Day